文献速递创伤与烧伤心脑血管急症重症综合管理与镇静镇痛

合并胸部创伤与创伤性脑损伤时生物标志物与更差结局相关

Concomitant chest trauma and traumatic brain injury, biomarkers correlate with worse outcomes.
PubMed 文献 · J Trauma Acute Care Surg · 2019-01-01
一句话结论严重TBI合并胸部创伤患者IL-4、IL-5、IL-8、IL-10升高而IFN-γ、IL-7降低,IL-4和神经元特异性烯醇化酶分别预测死亡。

本研究纳入57例严重创伤性脑损伤(TBI)患者,每6小时检测血清生物标志物共72小时,并评估基线、6小时和24小时头颅CT。比较合并胸部损伤(胸部简明损伤定级≥1)与无胸部损伤的TBI患者,发现合并胸部损伤者IL-4、IL-5、IL-8、IL-10平均水平更高,IFN-γ和IL-7更低。校正胸部损伤后IL-7预测神经功能恶化,ROC曲线下面积0.59(P=0.011);TBI合并胸部创伤患者IL-4和神经元特异性烯醇化酶分别预测死亡,ROC曲线下面积0.67和0.63(P=0.0001、0.003)。作者认为利用生物标志物早期识别TBI合并胸部创伤患者,可能改变影响该类患者并发症和死亡的因素。

要点

  • 严重TBI合并胸部损伤(胸部简明损伤定级≥1)患者IL-4、IL-5、IL-8、IL-10平均水平更高,IFN-γ和IL-7更低。
  • 校正胸部损伤后,IL-7预测神经功能恶化,ROC曲线下面积0.59(P=0.011)。
  • TBI合并胸部创伤患者中,IL-4预测死亡ROC曲线下面积0.67(P=0.0001),神经元特异性烯醇化酶预测死亡ROC曲线下面积0.63(P=0.003)。
  • 纳入57例严重TBI患者,平均年龄40.5岁,入院时中位运动格拉斯哥昏迷评分3分(四分位距1-5),24小时为5分(四分位距3-5)。
  • 12.2%患者在入院6小时内行开颅手术,22.8%在12小时内行开颅手术。

适用人群与场景

  • 严重创伤性脑损伤(TBI)患者,纳入本研究队列。
  • 合并胸部损伤定义为胸部简明损伤定级(Abbreviated Injury Scale chest score)≥1。
  • 合并胸部创伤患者中24.5%胸部简明损伤定级≥3,73.6%为钝性胸部创伤。

诊断标准与关键阈值

  • 神经功能恶化定义为挫伤增加、缺血、基底池受压和/或中线移位。
  • 胸部损伤判定标准:胸部简明损伤定级≥1。

研究设计与关键结果

  • 研究类型为创伤患者队列,纳入57例严重TBI患者,平均年龄40.5岁。
  • 入院时中位运动格拉斯哥昏迷评分3分(四分位距1-5),24小时中位运动格拉斯哥昏迷评分5分(四分位距3-5)。
  • 12.2%患者在入院6小时内行开颅手术,22.8%在12小时内行开颅手术。
  • 合并胸部损伤的TBI患者IL-4、IL-5、IL-8、IL-10平均水平高于无胸部损伤者,IFN-γ和IL-7平均水平低于无胸部损伤者。
  • 校正胸部损伤后,IL-7预测神经功能恶化,ROC曲线下面积0.59(P=0.011)。
  • TBI合并胸部创伤患者中,IL-4预测死亡ROC曲线下面积0.67(P=0.0001),神经元特异性烯醇化酶预测死亡ROC曲线下面积0.63(P=0.003)。

证据类型、等级与局限

  • 证据类型:创伤患者队列研究。
  • 证据等级:Level III。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,利用生物标志物早期识别TBI合并胸部创伤患者,可能改变影响该类患者并发症和死亡的因素。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Clinical data are lacking on the influence of chest trauma on the secondary injury process after traumatic brain injury (TBI), with some data suggesting that multiple trauma may worsens brain injury. Blunt chest trauma and TBI represent the two major single injury entities with the highest risk of complications and are potential biomarker targets.

METHODS: Trauma patients with severe TBI were enrolled. Serum biomarker levels were obtained every 6 hours for 72 hours. Baseline, 6 hours and 24 hours CT head scans were evaluated. Neurologic worsening was defined as increased contusions, ischemia, compression of basal cisterns, and/or midline shift. The TBI patients with chest injury (Abbreviated Injury Scale chest score ≥1) and those without chest injury were compared. Wilcoxon rank sum test, univariate logistic regression and receiver operating characteristic were reported.

RESULTS: Fifty-seven patients. Mean age of 40.5 years. Median motor Glasgow Coma Scale score at admission and 24 hours was 3 (interquartile range, 1-5) and 5 (interquartile range, 3-5). Of the patients enrolled, 12.2% patients underwent craniotomy within 6 hours from the time of admission and 22.8% within 12 hours. Patients with chest trauma, 24.5% had a chest Abbreviated Injury Scale score of 3 or greater, and 73.6% sustained blunt chest trauma. Stratifying TBI patients with and without chest injury revealed higher mean levels of IL-4, IL-5, IL-8, and IL-10 and lower mean IFN-γ and IL-7 levels in patient with chest injury. IL-7 levels adjusted for chest injury predicted neurological worsening with area under the receiver operating characteristic of 0.59 (p value = 0.011). The TBI and chest trauma patients' IL-4 and neuron-specific enolase levels were predictive of mortality (area under the receiver operating characteristic of 0.67 and 0.63, p = 0.0001, 0.003), respectively.

CONCLUSION: Utilizing biomarkers for early identification of patients with TBI and chest trauma has the capability of modifying adverse factors affecting morbidity and mortality in this subset of TBI patients.

LEVEL OF EVIDENCE: Level III.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Crawford AM, Yang S, Hu P, et al. Concomitant chest trauma and traumatic brain injury, biomarkers correlate with worse outcomes. J Trauma Acute Care Surg. 2019. PMID: 31246919. doi:10.1097/TA.0000000000002256

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。